raw sequencing data (Guardant Health)
Structured Review
Raw Sequencing Data, supplied by Guardant Health, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/raw+datas/data+raw+sequencing/pm42286014-191-0-9
Average 86 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial Article Snippet: Briefly, for the Article Title: The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial Article Snippet: For plasma processing, 20 to 30 mL of Article Title: The Prognostic and Predictive Impact of Circulating Tumour DNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial Article Snippet: The sequencing results generated by Article Title: The Prognostic and Predictive Impact of Circulating Tumour DNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial Article Snippet: For plasma processing, 20 to 30 mL of Sequencing:Article Title: Real-world cell-free circulating tumor DNA (ctDNA) analysis identifies CDK4/6 inhibitor resistance and tumor evolution in HR+ advanced breast cancer. Article Snippet: .. Article Title: Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer Study Article Snippet: .. Article Title: Detection of circulating tumor DNA using a tissue-free epigenomic assay is a highly prognostic biomarker in early-stage triple negative breast cancer Article Snippet: .. Generated:Article Title: Real-world cell-free circulating tumor DNA (ctDNA) analysis identifies CDK4/6 inhibitor resistance and tumor evolution in HR+ advanced breast cancer. Article Snippet: .. Article Title: Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer Study Article Snippet: .. Article Title: Detection of circulating tumor DNA using a tissue-free epigenomic assay is a highly prognostic biomarker in early-stage triple negative breast cancer Article Snippet: .. Clinical Proteomics:Article Title: Article Snippet: .. These samples are shipped to Guardant Health, where cfDNA is extracted from the plasma component of whole blood and prepared for analysis through the DNA Sequencing:Article Title: Article Snippet: .. These samples are shipped to Guardant Health, where cfDNA is extracted from the plasma component of whole blood and prepared for analysis through the |

![a) Log 2 ([elevated temperature/control] average total accumulation) of metabolic categories (n≥3) at six different seed developmental stages. b) Untargeted metabolomic data statistical analysis. c) Differentially accumulated metabolic features during seed development. d) Number of major metabolic categories (Flavonoids, Cinnamic acids and derivatives, and Glucosinolates) induced by elevated temperature at each seed developmental stage. e) <t>Transcriptomic</t> data statistical analysis. f) Differentially expressed genes during seed development. g) Percentages of genes coding for enzymes putatively involved in specialized metabolite modifications (Acyltransferases, Glycosyltransferases, Hydroxylases and Methyltransferases) induced, and repressed, at each seed developmental stage by elevated temperature.](https://bio-rxiv-images-cdn.bioz.com/dois_ending_with_04/10__64898_slash_2026__06__03__729804/10__64898_slash_2026__06__03__729804___F1.large.jpg)
